In the last trading session, U.S. stocks saw see-saw trading, falling for most of the day before rising again in late hours. Among the top ETFs, investors saw SPY gaining 0.8%, DIA adding 1.1%, and QQQ move higher by 0.4% on the day.
Two more specialized ETFs are worth noting as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra-interest continues:
FHLC: Volume 5.14 Times Average
This healthcare ETF was under the microscope as 2.1 million shares moved hands. This compares with an average trading day of roughly 439,000 shares and came as FHLC shed 1.1% in the trading session.
The big move was largely the result of high uncertainty, leading investors’ defensive tilt that can have a big impact on healthcare stocks like what we find in this ETF portfolio. FHLC has lost 7.1% over the past month and carries a Zacks ETF Rank #2 (Buy) with a Medium risk outlook.
SCHV: Volume 4.80 Times Average
This value ETF was in the spotlight as more than 4.2 million shares moved hands compared with an average of 939,000 shares a day. We also saw some price movement as SCHV gained 1% in the last session.
The movement can largely be blamed on heightened volatility that led to higher appeal for value ETFs. SCHV has shed 7.8% in a month’s time and carries a Zacks ETF Rank #1 (Strong Buy) with a Medium risk outlook.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
In the last trading session, U.S. stocks saw see-saw trading, falling for most of the day before rising again in late hours. Among the top ETFs, investors saw SPY gaining 0.8%, DIA adding 1.1%, and QQQ move higher by 0.4% on the day.
Two more specialized ETFs are worth noting as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra-interest continues:
FHLC: Volume 5.14 Times Average
This healthcare ETF was under the microscope as 2.1 million shares moved hands. This compares with an average trading day of roughly 439,000 shares and came as FHLC shed 1.1% in the trading session.
The big move was largely the result of high uncertainty, leading investors’ defensive tilt that can have a big impact on healthcare stocks like what we find in this ETF portfolio. FHLC has lost 7.1% over the past month and carries a Zacks ETF Rank #2 (Buy) with a Medium risk outlook.
SCHV: Volume 4.80 Times Average
This value ETF was in the spotlight as more than 4.2 million shares moved hands compared with an average of 939,000 shares a day. We also saw some price movement as SCHV gained 1% in the last session.
The movement can largely be blamed on heightened volatility that led to higher appeal for value ETFs. SCHV has shed 7.8% in a month’s time and carries a Zacks ETF Rank #1 (Strong Buy) with a Medium risk outlook.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on QQQ - FREE
Get the latest research report on SPY - FREE
Get the latest research report on DIA - FREE
Get the latest research report on SCHV - FREE
Get the latest research report on FHLC - FREE